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In the Brazilian Amazon, American tegumentary leishmaniasis (ATL) is endemic and presents a wide spectrum 
of clinical manifestations due, in part, to the circulation of at least seven Leishmania species. Few reports of Leish-
mania (Viannia) naiffi infection suggest that its occurrence is uncommon and the reported cases present a benign 
clinical course and a good response to treatment. This study aimed to strengthen the clinical and epidemiological 
importance of L. (V.) naiffi in the Amazon Region (Manaus, state of Amazonas) and to report therapeutic failure in 
patients infected with this species. Thirty Leishmania spp samples isolated from cutaneous lesions were character-
ised by multilocus enzyme electrophoresis. As expected, the most common species was Leishmania (V.) guyanensis 
(20 cases). However, a relevant number of L. (V.) naiffi patients (8 cases) was observed, thus demonstrating that 
this species is not uncommon in the region. No patient infected with L. (V.) naiffi evolved to spontaneous cure until 
the start of treatment, which indicated that this species may not have a self-limiting nature. In addition, two of the 
patients experienced a poor response to antimonial or pentamidine therapy. Thus, either ATL cases due to L. (V.) 
naiffi cannot be as uncommon as previously thought or this species is currently expanding in this region.
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American tegumentary leishmaniasis (ATL) is highly 
endemic in the state of Amazonas (AM), Brazil. Accord-
ing to the Information System on Notifiable Diseases 
database, 18,675 Brazilian cases were reported in 2013, 
8% of which occurred in the city of Manaus, AM (SVS/
MS 2015). In this region, control of the disease is consid-
ered difficult because of the epidemiological character-
istics and socioeconomic conditions associated with the 
sylvatic transmission cycle. In addition, environmental 
changes may influence infection dynamics, which makes 
control even more difficult. The circulation of at least 
seven Leishmania species has been observed in ATL in 
the Amazon Region. Leishmania (Viannia) guyanensis 
is the most prevalent species and is highly endemic in 
north of the Amazon River (Naiff et al. 1988, Grimaldi 
Jr et al. 1991, Lainson et al. 1994, Romero et al. 2001a, 
2002a, Guerra et al. 2003). In this sense, several studies 
have shown that the frequency of circulating species in 
this area varies (Table I) and that Leishmania (V.) naiffi 
seems to be more consistently isolated from cutaneous 
lesions in patients from this region.
L. (V.) naiffi was first described by Lainson and Shaw 
(1989) after being isolated from an armadillo (Dasypus 
novemcinctus) in the state of Pará, northern Brazil. The 
few cases described in the literature usually associate L. 
(V.) naiffi with low rates of virulence in humans. Thus, it 
has been described that the disease evolves with a benign 
clinical course and a good response to treatment (Naiff 
et al. 1991, Pratlong et al. 2002). Furthermore, two cases 
of spontaneous healing of leishmaniasis caused by L. (V.) 
naiffi were described (van der Snoek et al. 2009). To date, 
however, no association between L. (V.) naiffi and muco-
sal leishmaniasis has been observed. L. (V.) naiffi cutane-
ous leishmaniasis lesions are usually ulcerated, unique, 
small and located on the hands, arms or legs (Naiff et al. 
1991). In the same way, experimental studies have shown 
that L. (V.) naiffi frequently causes discrete or even non-
apparent infections on hamsters’ skin (Lainson & Shaw 
1989). These findings were supported by in vitro analysis, 
which demonstrated that L. (V.) naiffi showed the low-
est infection index and the highest nitric oxide produc-
tion compared with other species of the Viannia subgenus 
(Campos et al. 2008). Then, the clinical and experimental 
information previously reported supported the idea that 
infection by L. (V.) naiffi commonly results in benign 
manifestations. Therefore, the present study aimed to 
strengthen the awareness of the clinical and epidemiologi-
cal importance of L. (V.) naiffi in the Amazon Region and 
to report therapeutic failure associated with this species.
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Thirty Leishmania spp samples were isolated from 
cutaneous lesions of patients from different surrounding 
areas of Manaus. Samples were collected during 2011-
2013 at the Heitor Vieira Dourado Tropical Medicine 
Foundation (FMT-HVD), a reference centre for tropi-
cal diseases in AM. Skin lesion fragments obtained by 
biopsy were cultured in Novy-Neal-Nicolle medium 
and Leishmania was isolated. Parasites were sent to the 
Leishmania Collection from the Oswaldo Cruz Institute 
for species identification. This study was approved by 
the Research Ethical Committee of FMT-HVD (protocol 
21273572). Identification of Leishmania spp isolates was 
based on multilocus enzyme electrophoresis (MLEE) 
and performed on agarose gel and allelic variations were 
tested for the following enzymes: 6-phosphogluconate 
dehydrogenase (EC1.1.1.44), glucose-6-phosphate dehy-
drogenase (E.C.1.1.1.49) and isocitrate dehydrogenase 
(E.C.1.1.1.42). The method was performed in accordance 
with the conditions described by Cupolillo et al. (1994).
Four species were identified: L. (V.) guyanensis 
66.7% (20/30), L. (V.) naiffi 26.7% (8/30), Leishmania 
(Leishmania) amazonensis 3.3% (1/30) and Leishma-
nia (V.) shawi 3.3% (1/30). As expected, the most com-
mon species was L. (V.) guyanensis. Surprisingly, 
none of the isolates were characterised as L. (V.) brazi- 
liensis. According to Romero et al. (2002b), cases of ATL 
caused by L. (V.) braziliensis are uncommon in nearby 
Manaus. Interestingly, the frequency of L. (V.) naiffi was 
26.7% (8/30), which indicates that this species could be 
an etiologic agent of CL more frequent than expected 
in this region. These data corroborate those obtained by 
Figueira et al. (2008), who observed a relevant number 
of CL associated with L. (V.) naiffi in the municipalities 
of Rio Preto da Eva and Manaus.
Several methods have been used to define Leishma-
nia species (Degrave et al. 1994, Romero et al. 2001a, 
Coelho et al. 2011). Nevertheless, MLEE remains one 
of the main tools for characterising Leishmania because 
it reveals polymorphisms that express phenotypes of 
population variations and taxonomically classify the 
different species of this parasite (Cupolillo et al. 1994). 
Precise identification of Leishmania spp is fundamental 
to understanding the disease’s epidemiology; improving 
the current knowledge concerning its pathology and the 
control measures (Coelho et al. 2011). Thus, it is likely 
that the transmission of L. (V.) naiffi in the Amazon Re-
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gion is more frequent than has been reported. In this 
connection, the CL patients infected by L. (V.) naiffi (n 
= 8) are described below. All of them were men with 
a mean age of 37.4 ± 13.7 years (median = 37.5 years). 
The mean days of duration was 30 ± 24.8 days [median 
= 30 days (95% confidence interval: 22.5 - 52.5)]. The 
number of lesions ranged from one-four. Four subjects 
were initially treated with antimonial and four individu-
als were initially treated with pentamidine (antimonial: 
10-20 mg Sb+5/kg/day for 20/30 consecutive days; pent-
amidine: 3 doses of 4 mg/kg with an interval of 72 h be-
tween doses) (Table II). Two of the patients experienced 
a poor response to antimonial or pentamidine therapy.
Previous studies have suggested that the Leishmania 
species and the endemic area examined can be influ-
enced by the cure rate (Romero et al. 2001b, Arevalo et 
al. 2007). In a recent study conducted in AM, the cure 
rates in L. (V.) guyanensis infection after treatment with 
antimonial or pentamidine were 55.5% and 58.1%, re-
spectively (Neves et al. 2011). To date, all of the stud-
ies described in the literature have associated infection 
by L. (V.) naiffi with spontaneous healing or a good 
therapeutic response. However, the data obtained by our 
group showed therapeutic failure in a patient who was 
infected by L. (V.) naiffi and treated with pentamidine 
(R Vieira-Gonçalves, unpublished observations). Cor-
roborating this finding, we herein illustrate two new CL 
cases that are associated with L. (V.) naiffi infection and 
presented pentamidine or antimonial-resistant lesions 
(Table II), which indicates that the clinical evolution of 
infection from this species may not be as favourable as 
described. No cases of spontaneously healing was seem 
probably because the short period of disease duration 
until the diagnosis establishment. The cases of L. (V.) 
naiffi reported herein underline that this species may 
not have a self-limiting nature, as previously described 
(Naiff et al. 1991, van der Snoek et al. 2009), and could 
not be as uncommon as referenced (Grimaldi Jr et al. 
1991, Figueira et al. 2014). The present results highlight 
the importance of characterising Leishmania spp in ar-
eas that exhibit a sympatric circulation of Leishmania 
spp parasites to define the epidemiological importance 
of each of these species to human disease. This knowl-
edge can improve the surveillance and therapeutic ap-
proaches used to achieve a clinical cure.
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Demographic and clinical data of patients infected with Leishmania (Viannia) naiffi



















3 M 59 1 Upper limb 60 + Antimonial 
(20 doses)
Cure
4 M 30 1 Upper limb 15 + Antimonial 
(20 doses)
Cure
5 M 29 4 Upper limb 20 + Pentamidine 
(3 doses)
Cure
6 M 39 2 Lower limb 30 + Pentamidine 
(3 doses)
Cure
7 M 52 2 Face 30 + Antimonial 
(20 doses)
Cure
8 M 15 1 Lower limb 30 + Pentamidine 
(3 doses)
Cure
M: male; +: positive smears of scarifications.
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